Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
24.22
-1.26 (-4.94%)
Oct 3, 2024, 12:54 PM EDT - Market open
ARCT Employees
Arcturus Therapeutics Holdings had 180 employees as of December 31, 2023. The number of employees increased by 10 or 5.88% compared to the previous year.
Employees
180
Change (1Y)
10
Growth (1Y)
5.88%
Revenue / Employee
$910,367
Profits / Employee
-$399,789
Market Cap
654.96M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CureVac | 1,172 |
| Standard BioTools | 539 |
| Humacyte | 185 |
| Terns Pharmaceuticals | 66 |
| ABIVAX Société Anonyme | 61 |
| Tourmaline Bio | 44 |
| Savara | 37 |
ARCT News
- 3 days ago - Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-Vaccination - Business Wire
- 20 days ago - Japan's Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics' Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma - PRNewsWire
- 4 weeks ago - Arcturus Therapeutics Receives Clearance of an Investigational New Drug Application to U.S. Food and Drug Administration for ARCT-032, an Investigational Inhaled mRNA Therapeutic to Treat Cystic Fibrosis - Business Wire
- 5 weeks ago - Arcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences - Business Wire
- 7 weeks ago - High-Risk, High-Reward: Arcturus Nears Commercialization Of Kostaive Vaccine - Seeking Alpha
- 2 months ago - Arcturus Therapeutics Holdings Inc. (ARCT) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Arcturus Therapeutics Announces Second Quarter 2024 Financial Update and Pipeline Progress - Business Wire
- 2 months ago - Arcturus Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference - Business Wire